Optimisation Thérapeutique en Neuropsychopharmacologie
- World rank, 2022–2025
- #18,264 of 28,054 · #22,867 all time
- Rank in France
- #841 of 1,422
- Research works
- 172 ▲ 106% vs 2013–17
- Citations
- 3.1k 17.9 per fractional work
- Top-10% rate
- 17.8% record average 16.5%
- Open access
- 48% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 13.5×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 13.5×
- Veterinary 5.3×
- Neuroscience 4.0×
- Medicine 2.9×
- Biochemistry, Genetics and Molecular Biology 2.1×
- Immunology and Microbiology 2.0×
- Psychology 1.6×
- Health Professions 1.1×
- Nursing 1.1×
- Chemistry 0.7×
- Agricultural and Biological Sciences 0.4×
- Environmental Science 0.3×
- Dentistry 0.2×
- Materials Science 0.2×
- Social Sciences 0.2×
- Decision Sciences 0.2×
- Mathematics 0.1×
- Earth and Planetary Sciences 0.1×
- Engineering 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
Which keywords describe research at Optimisation Thérapeutique en Neuropsychopharmacologie?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Neuroimaging, Oxidative Stress, Inflammation, Neurobiology, Genetics, Biomarkers, Neurodegeneration and Neuroinflammation.
- Stroke
- Pharmacokinetics
- Mild Cognitive Impairment
- Cognitive Training
- Substance Use Disorders
- Genetic Variation
- Toxicity Assessment
- Drug Analysis
- Metabolism
- Treatment Guidelines
- Bipolar Spectrum Disorder
- Neurological Disorders
- Toxic Exposure Surveillance
- Diagnosis
- Prevalence
- Neurodegeneration
- Treatment
- Genetics
- Epidemiology
- Inflammation
- Oxidative Stress
- Neuroimaging
- Neurobiology
- Biomarkers
- Cognitive Function
- Neuroinflammation
- Aging
- Poison Control Centers
- Alzheimer's Disease
- Neuroprotection
- Suicide Risk
- Forensic Toxicology
- Designer Drugs
- Method Validation
- Dementia
- Mitochondrial Dysfunction
- Cognitive Decline
- Ischemic Stroke
- Mortality Risk
- Seizures
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Oxidative Stress6▲ 5.2×23 topics
- Inflammation5▲ 3.9×37 topics
- Neuroimaging5▲ 27×8 topics
- Epidemiology4▲ 1.52×47 topics
- Neurobiology4▲ 20×9 topics
- Genetics3▲ 6.9×10 topics
- Biomarkers3▲ 6.6×12 topics
- Treatment3▲ 3.5×22 topics
- Cognitive Function3▲ 21×5 topics
- Neurodegeneration3▲ 13×9 topics
- Neuroinflammation3▲ 14×6 topics
- Prevalence2▲ 9.2×7 topics
- Aging2▲ 6.6×10 topics
- Diagnosis2▲ 3.4×18 topics
- Poison Control Centers2▲ 200×1 topic
- Toxic Exposure Surveillance2▲ 200×1 topic
- Alzheimer's Disease2▲ 11×7 topics
- Neurological Disorders2▲ 5.4×12 topics
- Neuroprotection2▲ 8.0×9 topics
- Bipolar Spectrum Disorder2▲ 118×1 topic
- Suicide Risk2▲ 88×1 topic
- Treatment Guidelines2▲ 13×2 topics
- Forensic Toxicology2▲ 99×2 topics
- Metabolism2▲ 4.9×16 topics
- Designer Drugs2▲ 130×1 topic
- Drug Analysis2▲ 130×1 topic
- Method Validation2▲ 44×2 topics
- Toxicity Assessment2▲ 68×2 topics
- Dementia2▲ 24×2 topics
- Genetic Variation2▲ 11×3 topics
- Mitochondrial Dysfunction1▲ 7.3×9 topics
- Substance Use Disorders1▲ 29×2 topics
- Cognitive Decline1▲ 16×1 topic
- Cognitive Training1▲ 22×2 topics
- Ischemic Stroke1▲ 13×3 topics
- Mild Cognitive Impairment1▲ 23×1 topic
- Mortality Risk1▲ 8.1×4 topics
- Pharmacokinetics1▲ 7.4×8 topics
- Seizures1▲ 32×2 topics
- Stroke1▲ 10×6 topics
Which research topics does Optimisation Thérapeutique en Neuropsychopharmacologie publish most on?
By volume in 2022–2025: Poisoning and overdose treatments, Bipolar Disorder and Treatment, Forensic Toxicology and Drug Analysis and Dementia and Cognitive Impairment Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Poisoning and overdose treatments Emergency Medicine 2 works
- 2 Bipolar Disorder and Treatment Psychiatry and Mental health 2 works
- 3 Forensic Toxicology and Drug Analysis Toxicology 2 works
- 4 Dementia and Cognitive Impairment Research Psychiatry and Mental health 1 works
- 5 Alzheimer's disease research and treatments Physiology 1 works
- 6 Acute Ischemic Stroke Management Epidemiology 1 works
- 7 Neurological and metabolic disorders Endocrinology, Diabetes and Metabolism 1 works
- 8 Substance Abuse Treatment and Outcomes Epidemiology 1 works
- 9 Opioid Use Disorder Treatment Public Health, Environmental and Occupational Health 1 works
- 10 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Optimisation Thérapeutique en Neuropsychopharmacologie's research output changed?
Output in 2018–2022 was 106% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.